NOVOCURE LTD's ticker is NVCR and the CUSIP is G6674U108. A total of 107 filers reported holding NOVOCURE LTD in Q3 2017. The put-call ratio across all filers is 0.19 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $2,426 | -56.8% | 141,609 | -60.6% | 0.01% | -48.1% |
| Q1 2024 | $5,619 | +64.6% | 359,518 | +57.3% | 0.03% | -15.6% |
| Q4 2023 | $3,413 | +31.4% | 228,591 | +42.1% | 0.03% | +6.7% |
| Q3 2023 | $2,598 | +699.4% | 160,886 | +2880.5% | 0.03% | +650.0% |
| Q1 2023 | $325 | -47.3% | 5,398 | -35.9% | 0.00% | -50.0% |
| Q4 2022 | $617 | -100.0% | 8,415 | -66.7% | 0.01% | -66.7% |
| Q3 2022 | $1,917,000 | +702.1% | 25,236 | +633.8% | 0.02% | +700.0% |
| Q2 2022 | $239,000 | -81.6% | 3,439 | -78.1% | 0.00% | -70.0% |
| Q1 2022 | $1,300,000 | +31.3% | 15,696 | +19.0% | 0.01% | +100.0% |
| Q4 2021 | $990,000 | +54.7% | 13,189 | +139.6% | 0.01% | +66.7% |
| Q3 2021 | $640,000 | -72.7% | 5,505 | -48.0% | 0.00% | -72.7% |
| Q2 2021 | $2,346,000 | +67.6% | 10,577 | -0.1% | 0.01% | +57.1% |
| Q1 2021 | $1,400,000 | -5.5% | 10,591 | +23.8% | 0.01% | -12.5% |
| Q4 2020 | $1,481,000 | +509.5% | 8,558 | +108.7% | 0.01% | +300.0% |
| Q2 2020 | $243,000 | -81.3% | 4,100 | -78.8% | 0.00% | -83.3% |
| Q1 2020 | $1,301,000 | +134.0% | 19,317 | +192.9% | 0.01% | +140.0% |
| Q4 2019 | $556,000 | +103.7% | 6,596 | +80.5% | 0.01% | +150.0% |
| Q3 2019 | $273,000 | -54.4% | 3,654 | -61.4% | 0.00% | -50.0% |
| Q2 2019 | $599,000 | -79.5% | 9,471 | -84.4% | 0.00% | -85.2% |
| Q1 2019 | $2,917,000 | -20.8% | 60,565 | -45.0% | 0.03% | -15.6% |
| Q4 2018 | $3,685,000 | +122.9% | 110,053 | +249.0% | 0.03% | +166.7% |
| Q3 2018 | $1,653,000 | -22.9% | 31,537 | -53.9% | 0.01% | -36.8% |
| Q2 2018 | $2,143,000 | +1561.2% | 68,455 | +1058.5% | 0.02% | +1800.0% |
| Q1 2018 | $129,000 | +7.5% | 5,909 | -0.8% | 0.00% | 0.0% |
| Q4 2017 | $120,000 | -69.1% | 5,955 | -69.5% | 0.00% | -66.7% |
| Q3 2017 | $388,000 | +109.7% | 19,545 | +82.9% | 0.00% | +50.0% |
| Q2 2017 | $185,000 | +105.6% | 10,686 | -3.6% | 0.00% | +100.0% |
| Q1 2017 | $90,000 | -63.6% | 11,086 | -64.8% | 0.00% | -50.0% |
| Q4 2016 | $247,000 | +120.5% | 31,482 | +139.9% | 0.00% | +100.0% |
| Q3 2016 | $112,000 | – | 13,123 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| StepStone Group LP | 1,365,479 | $29,767,000 | 21.90% |
| Tamarack Advisers, LP | 1,115,000 | $24,307,000 | 11.56% |
| COURAGE CAPITAL MANAGEMENT LLC | 275,000 | $5,995,000 | 4.57% |
| GREAT POINT PARTNERS LLC | 753,481 | $16,426,000,000 | 2.44% |
| HARTLINE INVESTMENT CORP/ | 404,052 | $8,808,000 | 2.42% |
| Pier Capital, LLC | 346,350 | $7,550,000 | 1.29% |
| Rhenman & Partners Asset Management AB | 435,000 | $9,483,000 | 1.17% |
| HIGHLINE CAPITAL MANAGEMENT, L.P. | 1,029,910 | $22,452,000 | 0.77% |
| PEREGRINE CAPITAL MANAGEMENT LLC | 922,468 | $20,110,000 | 0.49% |
| Hodges Capital Management Inc. | 285,500 | $6,224,000 | 0.49% |